The U.S. Food and Drug Administration (FDA) has cleared Overjet’s AI Dental Assist product, marking it the first AI technology to enter the dental industry to aid dental hygienists and dentists in real time. The SaMD (Software as a Medical Device) will support the diagnosis and treatment of periodontal disease through measuring distal and mesial bone levels in bitewing as well as periapical radiographs. Periodontitis affects approximately 46% of the U.S. population, and if left untreated, can lead to tooth loss. Dr. Wardah Inam, PhD, CEO and Co-Founder of Overjet, stated, “Overjet’s Dental Assist clearance by the FDA is a landmark moment for dental AI. All clinicians can now have at their fingertips highly accurate software to detect and measure serious dental disease and clear AI visualizations to communicate with patients. This is big for dentistry and moving toward evidence-based, patient-centric care.”

Read more here.

More on: